{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:03:55Z","timestamp":1794647035995,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16493-5","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:18:48Z","timestamp":1755735528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["NMR based clinical metabolomics revealed altered lipid and sugar metabolism in systemic sclerosis with implications for diagnosis and therapeutic strategies"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-0896","authenticated-orcid":false,"given":"Gurvinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-4994","authenticated-orcid":false,"given":"Durgesh","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9450-5696","authenticated-orcid":false,"given":"Mohit Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7105-0281","authenticated-orcid":false,"given":"Atul","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-6739","authenticated-orcid":false,"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"16493_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet 390, 1685\u20131699 (2017).","journal-title":"Lancet"},{"key":"16493_CR2","doi-asserted-by":"publisher","first-page":"109267","DOI":"10.1016\/j.clim.2023.109267","volume":"248","author":"J Tian","year":"2023","unstructured":"Tian, J. et al. Global, regional, and National incidence and prevalence of systemic sclerosis. Clin. Immunol. 248, 109267 (2023).","journal-title":"Clin. Immunol."},{"key":"16493_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0019-5154.96193","volume":"57","author":"SK Ghosh","year":"2012","unstructured":"Ghosh, S. K., Bandyopadhyay, D., Saha, I. & Barua, J. K. Mucocutaneous and demographic features of systemic sclerosis: A profile of 46 patients from Eastern India. Indian J. Dermatology. 57, 201\u2013205 (2012).","journal-title":"Indian J. Dermatology"},{"key":"16493_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2174\/1568026619666181120141603","volume":"18","author":"A Guleria","year":"2018","unstructured":"Guleria, A., Kumar, A., Kumar, U., Raj, R. & Kumar, D. NMR based metabolomics: an exquisite and facile method for evaluating therapeutic efficacy and screening drug toxicity. Curr. Top. Med. Chem. 18, 1827\u20131849 (2018).","journal-title":"Curr. Top. Med. Chem."},{"key":"16493_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1586\/14737159.8.5.617","volume":"8","author":"GN Gowda","year":"2008","unstructured":"Gowda, G. N. et al. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn. 8, 617\u2013633 (2008).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"16493_CR6","doi-asserted-by":"crossref","unstructured":"Shanaiah, N., Zhang, S., Desilva, M. A. & Raftery, D. NMR-based metabolomics for biomarker discovery. In Biomarker Methods Drug Discovery Development. Methods in Pharmacology and Toxicology\u2122. (ed. Wang, F.) 341\u2013368 (Humana Press, 2008).","DOI":"10.1007\/978-1-59745-463-6_16"},{"key":"16493_CR7","doi-asserted-by":"publisher","first-page":"e0283283","DOI":"10.1371\/journal.pone.0283283","volume":"18","author":"J Ciaffi","year":"2023","unstructured":"Ciaffi, J. et al. Whole body insulin sensitivity is increased in systemic sclerosis. PloS One. 18, e0283283 (2023).","journal-title":"PloS One"},{"key":"16493_CR8","doi-asserted-by":"publisher","first-page":"102804","DOI":"10.1016\/j.autrev.2021.102804","volume":"20","author":"X Zhou","year":"2021","unstructured":"Zhou, X. et al. Antibody glycosylation in autoimmune diseases. Autoimmun. Rev. 20, 102804 (2021).","journal-title":"Autoimmun. Rev."},{"key":"16493_CR9","doi-asserted-by":"publisher","first-page":"975963","DOI":"10.3389\/fimmu.2022.975963","volume":"13","author":"M Morel","year":"2022","unstructured":"Morel, M. et al. Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy. Front. Immunol. 13, 975963 (2022).","journal-title":"Front. Immunol."},{"key":"16493_CR10","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2, 2692 (2007).","journal-title":"Nat. Protoc."},{"key":"16493_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0079-6565(95)01013-0","volume":"27","author":"Ala-Korpela","year":"1995","unstructured":"Ala-Korpela M. 1H NMR spectroscopy of human blood plasma. Progress Nucl. Magn. Reson. Spectrosc. 27, 475\u2013554 (1995).","journal-title":"Progress Nucl. Magn. Reson. Spectrosc."},{"key":"16493_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/mrc.4763","volume":"57","author":"D Dubey","year":"2019","unstructured":"Dubey, D. et al. Metabolite assignment of ultrafiltered synovial fluid extracted from knee joints of reactive arthritis patients using high resolution NMR spectroscopy. Magn. Reson. Chem. 57, 30\u201343 (2019).","journal-title":"Magn. Reson. Chem."},{"key":"16493_CR13","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1021\/acsomega.1c06941","volume":"7","author":"A Singh","year":"2022","unstructured":"Singh, A. et al. Serum metabolic disturbances in lung cancer investigated through an elaborative NMR-based serum metabolomics approach. ACS Omega. 7, 5510\u20135520 (2022).","journal-title":"ACS Omega"},{"key":"16493_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11011-021-00700-z","volume":"36","author":"U Kumar","year":"2021","unstructured":"Kumar, U. et al. An elaborative NMR based plasma metabolomics study revealed metabolic derangements in patients with mild cognitive impairment: a study on North Indian population. Metab. Brain Dis. 36, 957\u2013968 (2021).","journal-title":"Metab. Brain Dis."},{"key":"16493_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.12732\/ijpam.v94i3.2","volume":"94","author":"N Akarachantachote","year":"2014","unstructured":"Akarachantachote, N., Chadcham, S. & Saithanu, K. Cutoff threshold of variable importance in projection for variable selection. Int. J. Pure Appl. Math. 94, 307\u2013322 (2014).","journal-title":"Int. J. Pure Appl. Math."},{"key":"16493_CR16","doi-asserted-by":"publisher","first-page":"585161","DOI":"10.3389\/fmolb.2020.585161","volume":"7","author":"Z Smolenska","year":"2020","unstructured":"Smolenska, Z., Zabielska-Kaczorowska, M., Wojteczek, A., Kutryb-Zajac, B. & Zdrojewski, Z. Metabolic pattern of systemic sclerosis: association of changes in plasma concentrations of amino acid-related compounds with disease presentation. Front. Mol. Biosci. 7, 585161 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"16493_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/biomedicines10030607","volume":"10","author":"T Bogl","year":"2022","unstructured":"Bogl, T. et al. Plasma metabolomic profiling reveals four possibly disrupted mechanisms in systemic sclerosis. Biomedicines 10, 607 (2022).","journal-title":"Biomedicines"},{"key":"16493_CR18","doi-asserted-by":"publisher","first-page":"7626","DOI":"10.1038\/s41598-018-25992-7","volume":"8","author":"F Murgia","year":"2018","unstructured":"Murgia, F. et al. Metabolomic profile of systemic sclerosis patients. Sci. Rep. 8, 7626 (2018).","journal-title":"Sci. Rep."},{"key":"16493_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10067-022-06372-z","volume":"42","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis. Clin. Rheumatol. 42, 125\u2013134 (2023).","journal-title":"Clin. Rheumatol."},{"key":"16493_CR20","doi-asserted-by":"publisher","first-page":"155587","DOI":"10.1016\/j.metabol.2023.155587","volume":"144","author":"M Guo","year":"2023","unstructured":"Guo, M. et al. Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis. Metabolism 144, 155587 (2023).","journal-title":"Metabolism"},{"key":"16493_CR21","doi-asserted-by":"publisher","first-page":"e0159384","DOI":"10.1371\/journal.pone.0159384","volume":"11","author":"AA Bengtsson","year":"2016","unstructured":"Bengtsson, A. A. et al. Metabolic profiling of systemic lupus erythematosus and comparison with primary sj\u00f6gren\u2019s syndrome and systemic sclerosis. PloS One. 11, e0159384 (2016).","journal-title":"PloS One"},{"key":"16493_CR22","doi-asserted-by":"publisher","first-page":"21912","DOI":"10.1038\/s41598-020-78951-6","volume":"10","author":"C Meier","year":"2020","unstructured":"Meier, C. et al. Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease. Sci. Rep. 10, 21912 (2020).","journal-title":"Sci. Rep."},{"key":"16493_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fimmu.2020.00822","volume":"11","author":"A Ottria","year":"2020","unstructured":"Ottria, A. et al. Fatty acid and carnitine metabolism are dysregulated in systemic sclerosis patients. Front. Immunol. 11, 822 (2020).","journal-title":"Front. Immunol."},{"key":"16493_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/BOR.0000000000000824","volume":"34","author":"S O\u2019Reilly","year":"2022","unstructured":"O\u2019Reilly, S. Metabolic perturbations in systemic sclerosis. Curr. Opin. Rheumatol. 34, 91\u201394 (2022).","journal-title":"Curr. Opin. Rheumatol."},{"key":"16493_CR25","doi-asserted-by":"publisher","first-page":"14026","DOI":"10.1111\/jcmm.16013","volume":"24","author":"J Henderson","year":"2020","unstructured":"Henderson, J., Duffy, L., Stratton, R., Ford, D. & OG\u00c7\u00d6Reilly, S. Metabolic reprogramming of Glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis. J. Cell. Mol. Med. 24, 14026\u201314038 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"16493_CR26","first-page":"1","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Reviews Disease Primers. 1, 1\u201321 (2015).","journal-title":"Nat. Reviews Disease Primers"},{"key":"16493_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","volume":"6","author":"TR Katsumoto","year":"2011","unstructured":"Katsumoto, T. R., Whitfield, M. L. & Connolly, M. K. The pathogenesis of systemic sclerosis. Annu. Rev. Pathol. 6, 509\u2013537 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"16493_CR28","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nri2417","volume":"8","author":"JD Marth","year":"2008","unstructured":"Marth, J. D. & Grewal, P. K. Mammalian glycosylation in immunity. Nat. Rev. Immunol. 8, 874\u2013887 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"16493_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrrheum.2014.195","volume":"11","author":"NA Flavahan","year":"2015","unstructured":"Flavahan, N. A. A vascular mechanistic approach to Understanding Raynaud phenomenon. Nat. Rev. Rheumatol. 11, 146\u2013158 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"16493_CR30","doi-asserted-by":"crossref","unstructured":"Tomo, D. & Pietro, D. Myoinositol reduces inflammation and oxidative stress in human endothelial cells exposed in vivo tochronic hyperglycemia. Nutrients 13(7), 2210 (2021).","DOI":"10.3390\/nu13072210"},{"key":"16493_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2017.01.009","volume":"104","author":"O Zhenyukh","year":"2017","unstructured":"Zhenyukh, O. et al. High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation. Free Radic. Biol. Med. 104, 165\u2013177 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"16493_CR32","doi-asserted-by":"crossref","unstructured":"Morales-Gonz\u00e1lez, V. et al. Metabolic fingerprinting of systemic sclerosis: a systematic review. Front. Mol. Biosci. 10, 1\u201321 (2023).","DOI":"10.3389\/fmolb.2023.1215039"},{"key":"16493_CR33","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/rheumatology\/keu530","volume":"54","author":"S Jordan","year":"2015","unstructured":"Jordan, S., Maurer, B., Toniolo, M., Michel, B. & Distler, O. Performance of the new ACR\/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology 54, 1454\u20131458 (2015).","journal-title":"Rheumatology"},{"key":"16493_CR34","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy, E. C. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202\u2013205 (1988).","journal-title":"J. Rheumatol."},{"key":"16493_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jmr.2015.07.014","volume":"260","author":"GN Gowda","year":"2015","unstructured":"Gowda, G. N. & Raftery, D. Can NMR solve some significant challenges in metabolomics? J. Magn. Reson. 260, 144\u2013160 (2015).","journal-title":"J. Magn. Reson."},{"key":"16493_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.trac.2007.12.001","volume":"27","author":"DS Wishart","year":"2008","unstructured":"Wishart, D. S. Quantitative metabolomics using NMR. TRAC Trends Anal. Chem. 27, 228\u2013237 (2008).","journal-title":"TRAC Trends Anal. Chem."},{"key":"16493_CR37","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P Wurtz","year":"2017","unstructured":"Wurtz, P. et al. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on-omic technologies. Am. J. Epidemiol. 186, 1084\u20131096 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"16493_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2131\/jts.35.253","volume":"35","author":"I Ando","year":"2010","unstructured":"Ando, I. et al. Quantification of molecules in 1H-NMR metabolomics with formate as a concentration standard. J. Toxicol. Sci. 35, 253\u2013256 (2010).","journal-title":"J. Toxicol. Sci."},{"key":"16493_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/nbm.1940050404","volume":"5","author":"M Kriat","year":"1992","unstructured":"Kriat, M. et al. Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR Biomed. 5, 179\u2013184 (1992).","journal-title":"NMR Biomed."},{"key":"16493_CR40","doi-asserted-by":"publisher","first-page":"101009","DOI":"10.1016\/j.jaim.2024.101009","volume":"15","author":"S Rastogi","year":"2024","unstructured":"Rastogi, S., Verma, A., Trivedi, R., Shukla, A. & Kumar, D. Clinical metabolomics investigation of rheumatoid arthritis patients receiving ayurvedic whole system intervention. J. Ayurveda Integr. Med. 15, 101009 (2024).","journal-title":"J. Ayurveda Integr. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16493-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16493-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16493-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:56:38Z","timestamp":1757440598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16493-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16493-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Institute Ethics Committee of SGPGIMS, Lucknow (IEC Code: 2017-54-OTHER-96, File No. PGI\/BE\/94\/2018; dated 19 March 2018), approved the study. All the study participants provided written informed consent. The samples were obtained from Department of Clinical Immunology and Rheumatology SGPGIMS, Lucknow.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"30676"}}